Mydecine Innovations Group Announces Private Placement; Interim Changes to Management and Board of Directors

PharmaDrug Successfully Completes Key Milestone to Support cGMP Production of Clinical Lead Candidate PD-001, Its Patented, Orally Available Version of Cepharanthine for Oncology and Infectious Disease

Filament Health Announces Eighth Patent Issuance

PharmAla Biotech First Publicly Traded Company to Produce GMP MDMA